At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Not specified by the sponsor
- How long the study runs
- Study runs about 66 months (dates as stated)
- About the drug or intervention
- Not specified by the sponsor
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- Not specified
- Who
- All
- Number of participants
- 700
- Started
- 2022-10-04
- Last checked
- 2026-10
Plain English Summary
What is this study?
- • Testing a new treatment for cancer
- • Clinical study - 700 participants
- • The purpose of this multi-national disease registry is to collect prospectively (with longitudinal follow-up) high-quality, standardized, and contemporaneous data to capture changes in the non-small cell lung cancer (NSCLC) treatment landscape and outcomes over time
Who can take part?
- • Adults
- • Diagnosed with cancer
Where?
- • Torquay - Torbay Hospital
- • Huddersfield - Huddersfield Royal Infirmary
- • Bedford - Bedford General Hospital
- • Birmingham - Birmingham Heartlands Hospital
- • +11 more UK sites
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
The purpose of this multi-national disease registry is to collect prospectively (with longitudinal follow-up) high-quality, standardized, and contemporaneous data to capture changes in the non-small cell lung cancer (NSCLC) treatment landscape and outcomes over time. The registry will capture data on participants; demographic, clinical characteristics (including biomarker data), treatment patterns, and effectiveness and safety outcomes for advanced NSCLC with mesenchymal-epithelial transition exon 14(METex14) participants treated with systemic therapy.
More detail
This is a disease registry, which is an organized system using non-interventional methods to collect data on a patient population defined by a particular disease, exposure, or condition, and which is followed over time. Non-interventional means that after participants enrollment, participants will be treated according to the routine clinical treatment decision by the physician. The registry will not impose any treatment or procedure for participants.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: Not specified
- Who can join: All genders
What the study is looking for
- ✓Participants who signed ICF
- ✓Participants with advanced stage (stages IIIB-IV) NSCLC (all histologies) and Confirmed METex14 skipping alterations...
- ✓Participants who are starting or are already being treated with treatment that goes through your whole body
Who cannot take part
- ✗Participants who are enrolled in a clinical trial
See the full criteria
Where Is This Study? (15 UK sites)
Torbay Hospital
Torquay TQ2 7AA, United Kingdom
Huddersfield Royal Infirmary
Huddersfield HD3 3EA, United Kingdom
Bedford General Hospital
Bedford, United Kingdom
Birmingham Heartlands Hospital
Birmingham, United Kingdom
Royal Bournemouth Hospital
Bournemouth, United Kingdom
Velindre Cancer Centre
Cardiff CF14 2TL, United Kingdom
The Royal Marsden Hospital
Chelsea, United Kingdom
Northwick Park Hospital
Harrow, United Kingdom
Clatterbridge Cancer Centre - Liverpool
Liverpool, United Kingdom
Guy's Cancer Centre
London SE1 9RT, United Kingdom
Queen Elizabeth Hospital,Woolwich
London SE18 4QH, United Kingdom
St. George's Hospital
London SW17 0QT, United Kingdom
Charing Cross Hospital
London, United Kingdom
Preston Hospital
Preston, United Kingdom
Great Western Hospital
Swindon SN3 6BB, United Kingdom
How to Get in Touch
US Medical Information
Sponsor contactCONTACT
Communication Center
Sponsor contactCONTACT